| # | % | |||||
|---|---|---|---|---|---|---|
| 201 | Elite Pharmaceuticls New | 7,500 | 1,000 | 0.00% | ||
| 202 | GABELLI GLB SML & MD CP VAL TR | 100 | 1,000 | 0.00% | ||
| 203 | SELECT SECTOR SPDR TR | 30 | 1,000 | 0.00% | ||
| 204 | VIVUS INC | 500 | 1,000 | 0.00% | ||
| 205 | KEYSIGHT TECHNOLOGIES INC COM | 19 | 1,000 | 0.00% | ||
| 206 | VECTRUS INC | 40 | 1,000 | 0.00% | ||
| 207 | Monitise PLC Ord | 10,000 | 0 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000924166-16-000016, filed 2016.11.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.